Smarter brain stimulator could save battery life in Parkinson's patients

NCT ID NCT07106242

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a new type of deep brain stimulation (DBS) called adaptive DBS (aDBS) in 25 people with Parkinson's disease. Unlike standard continuous DBS, aDBS adjusts stimulation in real time based on brain signals. The goal was to see if aDBS uses less total electrical energy while still controlling symptoms. Participants were already implanted with a compatible DBS system and had previously tolerated aDBS. The study compared energy use between aDBS and standard DBS over two weeks each.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
adaptive deep brain stimulation (aDBS) device
What this could lead to
If successful, this could lead to more efficient, longer-lasting deep brain stimulation for Parkinson's, potentially reducing battery changes and side effects.
What could go wrong
This is a small, completed study (25 people) focused on energy use, not direct symptom improvement. Results may not apply to all Parkinson's patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Juntendo University Hospital

    Bunkyo-ku, Tokyo, 113-0033, Japan

  • Juntendo University Nerima Hospital

    Tokyo, Nerima-ku, 177-8521, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.